Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysyl hydroxylase is an enzyme that catalyzes the hydroxylation of lysine residues in collagen, a post-translational modification critical for collagen cross-linking and stability. There are three isoforms (LH1, LH2, LH3), each with distinct substrate preferences. Inhibiting lysyl hydroxylase can disrupt collagen maturation and stability, impacting the structure of connective tissues.
Inhibition of lysyl hydroxylation, leading to disruption of collagen cross-linking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysyl Hydroxylase (LH).